Corbus Pharmaceuticals announced it will present late-breaking data from its Phase 1B CANYON-1 study of CRB-913, an oral drug targeting obesity, at Obesity Week 2026 in November. The presentation will cover the drug's efficacy, safety, and tolerability, highlighting its potential as a new treatment option. This event is significant as CRB-913 showed promising weight loss results in earlier trials. Investors and stakeholders will watch for detailed clinical insights that could impact Corbus's development plans and market positioning in obesity therapies.
Corbus Pharmaceuticals' upcoming presentation of CRB-913 data provides context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Oct 22, 2026 19:13 WIB: out of 150 priced health-sector US stocks, 63 rose and 79 fell. Notable movers include RXRX at USD 3.53 with a 3.02% decline and 100% buy order activity, ZBH at USD 97.49 up 2.77%, and TXG at USD 73.55 down 2.70% with 100% buy order activity.
Flutter Entertainment, a leading online sports betting and iGaming operator, will release its third quarter 2026 update on November 4 before the US market opens. The company will host a conference call at 8:30 a.m. ET the same day to discuss the resu...
iPower Inc. declared a 1-for-12 reverse stock split effective October 26, 2026, combining every 12 shares into one to increase the stock price. This move aims to keep iPower's shares compliant with Nasdaq's minimum bid price requirements. Post-split,...
U.S. Global Investors has listed its actively managed U.S. Global Technology and Aerospace & Defense ETF (WAR) on Peru's Lima Stock Exchange, marking the first availability of this ETF outside the U.S. This move gives Peruvian investors access to a f...
Alignment Health Plan will launch a new Medicare Advantage plan in Pima County starting January 1, 2027, increasing access to affordable, coordinated healthcare for nearly 1.1 million Medicare beneficiaries across Maricopa, Pima, and Santa Cruz count...
The global Urban Air Mobility (UAM) market is projected to grow from $2.16 billion in 2026 to $16.27 billion by 2035, at a CAGR of 20.9%. This growth is fueled by rising urbanization, traffic congestion, and advances in electric vertical takeoff and ...
